Chinese herbal medicine alleviates the pathogenesis of polycystic ovary syndrome by improving oxidative stress and glucose metabolism via mitochondrial Sirtuin 3 signaling - PubMed (original) (raw)
Chinese herbal medicine alleviates the pathogenesis of polycystic ovary syndrome by improving oxidative stress and glucose metabolism via mitochondrial Sirtuin 3 signaling
Qing Zhang et al. Phytomedicine. 2023 Jan.
Abstract
Background: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders among women, and the curative effects of its current management are not satisfactory. A formula of Chinese herbal medicine (CHM), called Bu-Shen-Tian-Jing Formula (BSTJF), has clinically shown beneficial effects in treating PCOS.
Purpose: This study aimed to investigate the mechanism underlying BSTJF for treatment of PCOS.
Methods: Whole blood samples were collected from women with PCOS treated and not treated with BSTJF (n = 5 per group). Whole transcriptome sequencing of leukocytes and untargeted metabonomic analysis of the plasma were performed. Three groups of 18 female Sprague-Dawley rats were randomly selected: control, PCOS, and BSTJF. A PCOS rat model was established using testosterone propionate. The estrous cycle; glucose tolerance; ovarian morphology; serum markers of oxidative stress; and expression of Sirtuin 3 (SIRT3), phospho-p38 mitogen-activated protein kinase, phosphatidylinositol 3-kinase (PI3K), and phospho-protein kinase B in the ovary were measured. Palmitate was initially applied to KGN cells, followed by freeze-dried BSTJF powder. The glucose uptake, reactive oxygen species (ROS) production, and protein levels of SIRT3, PI3K, and glucose transporter type 4 (GLUT4) were detected in KGN cells.
Results: The transcriptomic and metabolomic profiles showed alterations in 572 genes and 73 metabolites in women with PCOS treated with BSTJF. The enriched pathways in women with PCOS treated with BSTJF were mainly involved in inflammation, insulin resistance, glucose and lipid metabolism, and neuro and associated signaling pathways. In PCOS rat models, BSTJF improved the estrous cycle, glucose tolerance, and ovarian morphology; relieved oxidative stress; increased ovarian SIRT3 expression; inhibited p38 MAPK activation; and promoted the activation of PI3K/AKT signaling in the ovary. In the in-vitro study with KGN cells, BSTJF rescued the palmitate-induced impaired glucose uptake and SIRT3 expression, reduced mitochondrial ROS production mediated by SIRT3, and restored the impaired insulin-induced PI3K/AKT signaling pathway.
Conclusion: BSTJF effectively alleviated the pathogenesis of PCOS by improving oxidative stress and glucose metabolism via mitochondrial SIRT3 and the following insulin signaling pathway. This study innovatively revealed the action mechanism of CHM in treating PCOS.
Keywords: Bu-Shen-Tian-Jing formula; Glucose metabolism; Polycystic ovary syndrome; Sirtuin 3.
Copyright © 2022 Elsevier GmbH. All rights reserved.
Conflict of interest statement
Conflict of interest All authors declare that there are no conflicts of interest.
Similar articles
- Guizhi Fuling Wan reduces autophagy of granulosa cell in rats with polycystic ovary syndrome via restoring the PI3K/AKT/mTOR signaling pathway.
Liu M, Zhu H, Zhu Y, Hu X. Liu M, et al. J Ethnopharmacol. 2021 Apr 24;270:113821. doi: 10.1016/j.jep.2021.113821. Epub 2021 Jan 16. J Ethnopharmacol. 2021. PMID: 33460753 - Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
Qiu Z, Dong J, Xue C, Li X, Liu K, Liu B, Cheng J, Huang F. Qiu Z, et al. J Ethnopharmacol. 2020 Mar 25;250:111965. doi: 10.1016/j.jep.2019.111965. Epub 2019 Jun 8. J Ethnopharmacol. 2020. PMID: 31185267 - Neurobehavioral alternations of the female offspring born to polycystic ovary syndrome model rats administered by Chinese herbal medicine.
Zhang X, You L, Zhang X, Wang F, Wang Y, Zhou J, Liu C, Qu F. Zhang X, et al. Chin Med. 2021 Oct 2;16(1):97. doi: 10.1186/s13020-021-00512-4. Chin Med. 2021. PMID: 34600579 Free PMC article. - Role of the PI3K-Akt Signaling Pathway in the Pathogenesis of Polycystic Ovary Syndrome.
Li T, Mo H, Chen W, Li L, Xiao Y, Zhang J, Li X, Lu Y. Li T, et al. Reprod Sci. 2017 May;24(5):646-655. doi: 10.1177/1933719116667606. Epub 2016 Sep 9. Reprod Sci. 2017. PMID: 27613818 Review.
Cited by
- Modulation of the RAC1/MAPK/ERK signalling pathway by farnesyl diphosphate synthase regulates granulosa cells proliferation in polycystic ovary syndrome.
Guo X, Cao Y, He Q, Chen L, Wang Q, Zhang J, Lv W, Zhang B, Zhou X. Guo X, et al. Hum Cell. 2024 May;37(3):689-703. doi: 10.1007/s13577-024-01050-5. Epub 2024 Mar 29. Hum Cell. 2024. PMID: 38551774 - Berberine Protects Against Dihydrotestosterone-Induced Human Ovarian Granulosa Cell Injury and Ferroptosis by Regulating the Circ_0097636/MiR-186-5p/SIRT3 Pathway.
Wang S, Wang Y, Qin Q, Li J, Chen Q, Zhang Y, Li X, Liu J. Wang S, et al. Appl Biochem Biotechnol. 2024 Aug;196(8):5265-5282. doi: 10.1007/s12010-023-04825-y. Epub 2023 Dec 28. Appl Biochem Biotechnol. 2024. PMID: 38153651 - Current Advances in Cellular Approaches for Pathophysiology and Treatment of Polycystic Ovary Syndrome.
Tsai YR, Liao YN, Kang HY. Tsai YR, et al. Cells. 2023 Aug 31;12(17):2189. doi: 10.3390/cells12172189. Cells. 2023. PMID: 37681921 Free PMC article. Review. - Effects of TCM on polycystic ovary syndrome and its cellular endocrine mechanism.
Chen H, Deng C, Meng Z, Meng S. Chen H, et al. Front Endocrinol (Lausanne). 2023 May 16;14:956772. doi: 10.3389/fendo.2023.956772. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37260441 Free PMC article. Review. - Why Is Longevity Still a Scientific Mystery? Sirtuins-Past, Present and Future.
Ziętara P, Dziewięcka M, Augustyniak M. Ziętara P, et al. Int J Mol Sci. 2022 Dec 31;24(1):728. doi: 10.3390/ijms24010728. Int J Mol Sci. 2022. PMID: 36614171 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical